Market Place
Sourcing Support
Ligand Partner Travere Gets Full FDA Approval For FILSPARI In IgA
06 Sep 2024 //
BUSINESSWIRE
Context Therapeutics Appoints Two New Board Members
04 Sep 2024 //
GLOBENEWSWIRE
IOL Chemicals secures patent for invention related to preparation of Sartan drugs
27 Nov 2022 //
BUSINESS-STANDARD
Enforcement Report - Week of August 3, 2022
03 Aug 2022 //
FDA
Enforcement Report - Week of November 11, 2021
10 Nov 2021 //
FDA
Recall of six batches of Aprovel Film-Coated Tablet 150MG, Coaprovel
01 Nov 2021 //
HSA
Multiple lots of irbesartan, losartan and valsartan drugs recalled
17 Sep 2021 //
NEWSWIRE
Sanofi pulls hypertension meds in Korea, Canada and the UK
11 Aug 2021 //
FIERCEPHARMA
MHRA recalls contaminated Irbesartan- batches as precautionary measure
09 Aug 2021 //
MHRA
MHRA Class 2 Medicines Recall: Irbesartan & Losartan containing products : PSNC
18 Jun 2021 //
FIRSTWORDPHARMA
UK MHRA recalls contaminated Irbesartan and Losartan batches
17 Jun 2021 //
PHARMABIZ
Health Canada Issues Recall of Multiple lots of Irbesartan, losartan & valsartan drugs
15 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sanofi-Aventis` Avalide
14 Jun 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sanofi-Aventis` Avapro
14 Jun 2021 //
HEALTH CANADA
Sandoz Canada Inc Issues Recall of Sandoz-Irbesartan Product
31 May 2021 //
HEALTH CANADA
Health Canada Issues Recall of Pro Doc`s Irbesartan/HCTZ
27 May 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sun Pharma Canada`s RAN-Irbesartan
27 May 2021 //
HEALTH CANADA
Mint Pharmaceuticals Inc Issues Recall of MINT-Irbesartan/HCTZ Product
27 May 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sivem Pharmaceuticals` Irbesartan
26 May 2021 //
HEALTH CANADA
Health Canada Issues Recall of Sivem Pharmaceuticals` Irbesartan/HCT
26 May 2021 //
HEALTH CANADA
Health Canada Issues Recall of Pharmascience Irbesartan
25 May 2021 //
HEALTH CANADA
6 Major Drug Recalls from the Past
17 Oct 2019 //
BIOSPACE
FDA tags Torrent as key offender in production of tainted blood pressure meds
17 Oct 2019 //
FIERCE PHARMA
FDA says widening probe on generic drug impurities
29 Aug 2019 //
REUTERS
FDA Sends Warning Letters to Aurobindo, API Repackers
03 Jul 2019 //
RAPS
Aurobindo gets warning letter over valsartan recall mess
03 Jul 2019 //
FIERCE PHARMA
FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India
18 May 2019 //
RAPS
Health Canada Issues Recall of Auro Pharma Auro-Irbesartan HCT Tablet
18 Apr 2019 //
HEALTH CANADA
Pro Doc Limitée recalls 2 lots of irbesartan because of nitrosamine impurity
18 Mar 2019 //
HEALTH CANADA
FDA finds new cancer-causing impurity in blood pressure pills
02 Mar 2019 //
CNBC
TGA investigation - potential contamination with N-nitroso compounds
26 Feb 2019 //
TGA
Enforcement Report - Week of February 6, 2019
06 Feb 2019 //
FDA
Update on the EDQM review of CEP applications for sartan substances (4 Feb 2019)
04 Feb 2019 //
EDQM
Irbesartan distributed by Solco Healthcare voluntarily recalled
19 Jan 2019 //
FDA
Irbesartan products under recall - Updated January 18, 2019
19 Jan 2019 //
FDA
43 popular heart drugs found to contain carcinogens in Taiwan
19 Jan 2019 //
TAIWAN NEWS
Update on the review of CEP applications for sartans (18 Jan 2019)
18 Jan 2019 //
EDQM
Blood pressure drug recall: FDA investigates foreign manufacturers
14 Jan 2019 //
USA TODAY
EU Regulatory Roundup: UK NHS Calls for Changes to Pricing Legislation
11 Jan 2019 //
RAPS
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
Irbesartan blood pressure and heart medication recalled from pharmacies by MHRA
03 Jan 2019 //
GOV UK
Class 2 Medicines Recall: Actavis recall of batches of Irbesartan / HCTZ Tablets
03 Jan 2019 //
GOV UK
FDA presents interim limits of nitrosamines in currently marketed ARBs
21 Dec 2018 //
FDA
Irbesartan products under recall - Updated October 29, 2018
20 Dec 2018 //
FDA
Enforcement Report - Week of December 19, 2018
19 Dec 2018 //
FDA
Zhejiang Huahai lambasted in FDA warning for putting profits ahead of safety
12 Dec 2018 //
FIERCE PHARMA
FDA warns API manufacturer involved in valsartan recall
12 Dec 2018 //
FDA
Mylan expands its voluntary recall of valsartan-containing products
10 Dec 2018 //
FDA
Walmart and Aurobindo sued as litigation mounts over contaminated blood pressure drugs
08 Dec 2018 //
FIERCE PHARMA
MHRA recalls Valsartan blood pressure and heart medication from pharmacies
30 Nov 2018 //
GOV UK
Enforcement Report - Week of November 28, 2018
28 Nov 2018 //
FDA
EMA Warns of Impurity in Valsartan From Mylan
20 Nov 2018 //
RAPS
